Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109013039> ?p ?o ?g. }
- W2109013039 endingPage "237" @default.
- W2109013039 startingPage "224" @default.
- W2109013039 abstract "Standard chemotherapy can cure only a fraction (30-40%) of younger and very few older patients with acute myeloid leukemia (AML). While conventional allografting can extend the cure rates, its application remains limited mostly to younger patients and those in remission. Limited efficacy of current therapies and improved understanding of the disease biology provided a spur for clinical trials examining novel agents and therapeutic strategies in AML. Clinical studies with novel chemotherapeutics, antibodies, different signal transduction inhibitors, and epigenetic modulators demonstrated their clinical activity; however, it remains unclear how to successfully integrate novel agents either alone or in combination with chemotherapy into the overall therapeutic schema for AML. Further studies are needed to examine their role in relation to standard chemotherapy and their applicability to select patient populations based on recognition of unique disease and patient characteristics, including the development of predictive biomarkers of response. With increasing use of nonmyeloablative or reduced intensity conditioning and alternative graft sources such as haploidentical donors and cord blood transplants, the benefits of allografting may extend to a broader patient population, including older AML patients and those lacking a HLA-matched donor. We will review here recent clinical studies that examined novel pharmacologic and immunologic approaches to AML therapy. Keywords: Acute myeloid leukemia, chemotherapy, novel agents, transplant." @default.
- W2109013039 created "2016-06-24" @default.
- W2109013039 creator A5046719320 @default.
- W2109013039 creator A5051026089 @default.
- W2109013039 creator A5056345529 @default.
- W2109013039 date "2012-07-01" @default.
- W2109013039 modified "2023-10-14" @default.
- W2109013039 title "New Treatment Approaches in Acute Myeloid Leukemia: Review of Recent Clinical Studies" @default.
- W2109013039 cites W107098111 @default.
- W2109013039 cites W118967028 @default.
- W2109013039 cites W1492445977 @default.
- W2109013039 cites W1492609361 @default.
- W2109013039 cites W1519562949 @default.
- W2109013039 cites W1586763410 @default.
- W2109013039 cites W1861929829 @default.
- W2109013039 cites W1930980342 @default.
- W2109013039 cites W1940598690 @default.
- W2109013039 cites W1965658643 @default.
- W2109013039 cites W1965832312 @default.
- W2109013039 cites W1973097976 @default.
- W2109013039 cites W1974740049 @default.
- W2109013039 cites W1978659582 @default.
- W2109013039 cites W1980451195 @default.
- W2109013039 cites W1981811959 @default.
- W2109013039 cites W1982247089 @default.
- W2109013039 cites W1984236357 @default.
- W2109013039 cites W1987350756 @default.
- W2109013039 cites W1990135782 @default.
- W2109013039 cites W1995900951 @default.
- W2109013039 cites W1996708547 @default.
- W2109013039 cites W1998822622 @default.
- W2109013039 cites W1999445041 @default.
- W2109013039 cites W2005984068 @default.
- W2109013039 cites W2010222433 @default.
- W2109013039 cites W2012538864 @default.
- W2109013039 cites W2016883830 @default.
- W2109013039 cites W2016937505 @default.
- W2109013039 cites W2017196865 @default.
- W2109013039 cites W2018883183 @default.
- W2109013039 cites W2018953748 @default.
- W2109013039 cites W201908734 @default.
- W2109013039 cites W2021378114 @default.
- W2109013039 cites W2021727607 @default.
- W2109013039 cites W2024614395 @default.
- W2109013039 cites W2025712796 @default.
- W2109013039 cites W2025754007 @default.
- W2109013039 cites W2028795322 @default.
- W2109013039 cites W2029595590 @default.
- W2109013039 cites W2034544947 @default.
- W2109013039 cites W203809443 @default.
- W2109013039 cites W2039334806 @default.
- W2109013039 cites W2043133976 @default.
- W2109013039 cites W2043216151 @default.
- W2109013039 cites W2045528227 @default.
- W2109013039 cites W2046689400 @default.
- W2109013039 cites W2049722365 @default.
- W2109013039 cites W2051763439 @default.
- W2109013039 cites W2051987542 @default.
- W2109013039 cites W2058188142 @default.
- W2109013039 cites W2060311019 @default.
- W2109013039 cites W2066124347 @default.
- W2109013039 cites W2066812263 @default.
- W2109013039 cites W2069448515 @default.
- W2109013039 cites W2070012795 @default.
- W2109013039 cites W2074425311 @default.
- W2109013039 cites W2076744639 @default.
- W2109013039 cites W2077425645 @default.
- W2109013039 cites W2078090409 @default.
- W2109013039 cites W2079025304 @default.
- W2109013039 cites W2081391009 @default.
- W2109013039 cites W2084267226 @default.
- W2109013039 cites W2087607698 @default.
- W2109013039 cites W2090804690 @default.
- W2109013039 cites W2091371557 @default.
- W2109013039 cites W2092449369 @default.
- W2109013039 cites W2093583314 @default.
- W2109013039 cites W2097071879 @default.
- W2109013039 cites W2097192169 @default.
- W2109013039 cites W2098290171 @default.
- W2109013039 cites W2098925112 @default.
- W2109013039 cites W2099212333 @default.
- W2109013039 cites W2099427002 @default.
- W2109013039 cites W2107029748 @default.
- W2109013039 cites W2109065151 @default.
- W2109013039 cites W2109150359 @default.
- W2109013039 cites W2110828128 @default.
- W2109013039 cites W2114942826 @default.
- W2109013039 cites W2118250079 @default.
- W2109013039 cites W2120440386 @default.
- W2109013039 cites W2125080520 @default.
- W2109013039 cites W2125695832 @default.
- W2109013039 cites W2126572589 @default.
- W2109013039 cites W2127080762 @default.
- W2109013039 cites W2127568389 @default.
- W2109013039 cites W2128812336 @default.
- W2109013039 cites W2129615499 @default.
- W2109013039 cites W2131072337 @default.
- W2109013039 cites W2131637500 @default.